167 related articles for article (PubMed ID: 23481365)
1. L32. ANCA vasculitis over the world. What do we learn from country differences?
Watts RA; Scott DG
Presse Med; 2013 Apr; 42(4 Pt 2):591-3. PubMed ID: 23481365
[No Abstract] [Full Text] [Related]
2. L31. A GWAS in ANCA-associated vasculitis: will genetics help re-define clinical classification?
Lyons PA; Smith KG
Presse Med; 2013 Apr; 42(4 Pt 2):589-91. PubMed ID: 23490642
[No Abstract] [Full Text] [Related]
3. L27. Antibodies versus phenotypes: a clinician's view.
Jayne D
Presse Med; 2013 Apr; 42(4 Pt 2):579-82. PubMed ID: 23490640
[No Abstract] [Full Text] [Related]
4. ANCA-associated vasculitis in childhood: recent advances.
Calatroni M; Oliva E; Gianfreda D; Gregorini G; Allinovi M; Ramirez GA; Bozzolo EP; Monti S; Bracaglia C; Marucci G; Bodria M; Sinico RA; Pieruzzi F; Moroni G; Pastore S; Emmi G; Esposito P; Catanoso M; Barbano G; Bonanni A; Vaglio A
Ital J Pediatr; 2017 May; 43(1):46. PubMed ID: 28476172
[TBL] [Abstract][Full Text] [Related]
5. L29. Relevance of anti-LAMP-2 in vasculitis: why the controversy.
Kain R
Presse Med; 2013 Apr; 42(4 Pt 2):584-8. PubMed ID: 23453500
[No Abstract] [Full Text] [Related]
6. Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.
Merkel PA; Xie G; Monach PA; Ji X; Ciavatta DJ; Byun J; Pinder BD; Zhao A; Zhang J; Tadesse Y; Qian D; Weirauch M; Nair R; Tsoi A; Pagnoux C; Carette S; Chung S; Cuthbertson D; Davis JC; Dellaripa PF; Forbess L; Gewurz-Singer O; Hoffman GS; Khalidi N; Koening C; Langford CA; Mahr AD; McAlear C; Moreland L; Seo EP; Specks U; Spiera RF; Sreih A; St Clair EW; Stone JH; Ytterberg SR; Elder JT; Qu J; Ochi T; Hirano N; Edberg JC; Falk RJ; Amos CI; Siminovitch KA;
Arthritis Rheumatol; 2017 May; 69(5):1054-1066. PubMed ID: 28029757
[TBL] [Abstract][Full Text] [Related]
7. L34. Neutrophils in ANCA-associated vasculitis: still under investigation.
Witko-Sarsat V
Presse Med; 2013 Apr; 42(4 Pt 2):595-7. PubMed ID: 23481359
[No Abstract] [Full Text] [Related]
8. Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
Postgrad Med J; 2014 May; 90(1063):290-6. PubMed ID: 24737903
[TBL] [Abstract][Full Text] [Related]
9. Genetically distinct subsets within ANCA-associated vasculitis.
Lyons PA; Rayner TF; Trivedi S; Holle JU; Watts RA; Jayne DR; Baslund B; Brenchley P; Bruchfeld A; Chaudhry AN; Cohen Tervaert JW; Deloukas P; Feighery C; Gross WL; Guillevin L; Gunnarsson I; Harper L; Hrušková Z; Little MA; Martorana D; Neumann T; Ohlsson S; Padmanabhan S; Pusey CD; Salama AD; Sanders JS; Savage CO; Segelmark M; Stegeman CA; Tesař V; Vaglio A; Wieczorek S; Wilde B; Zwerina J; Rees AJ; Clayton DG; Smith KG
N Engl J Med; 2012 Jul; 367(3):214-23. PubMed ID: 22808956
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K.
Fujimoto S; Watts RA; Kobayashi S; Suzuki K; Jayne DR; Scott DG; Hashimoto H; Nunoi H
Rheumatology (Oxford); 2011 Oct; 50(10):1916-20. PubMed ID: 21798892
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of case-finding algorithms for the identification of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis in large healthcare administrative databases.
Sreih AG; Annapureddy N; Springer J; Casey G; Byram K; Cruz A; Estephan M; Frangiosa V; George MD; Liu M; Parker A; Sangani S; Sharim R; Merkel PA;
Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1368-1374. PubMed ID: 27804171
[TBL] [Abstract][Full Text] [Related]
12. [Recommendations on the diagnosis and treatment of anti-neutrophil cytoplasmic antibody associated vasculitis in China].
Tian XP; Zhao LK; Jiang ZY; Wang Y; Huang CB; Zhao Y
Zhonghua Nei Ke Za Zhi; 2022 Oct; 61(10):1128-1135. PubMed ID: 36207967
[TBL] [Abstract][Full Text] [Related]
13. L43. Seropositive and negative ANCA-associated vasculitis, anti-MPO and PR3-vasculitis: different outcomes?
Holle JU
Presse Med; 2013 Apr; 42(4 Pt 2):616-9. PubMed ID: 23481358
[No Abstract] [Full Text] [Related]
14. HLA-DPB1 variant rs3117242 is associated with anti-neutrophil cytoplasmic antibody-associated vasculitides in a Han Chinese population.
Wu Z; Wu Q; Xu J; Chen S; Sun F; Li P; Bai Y; Zheng W; Chen H; Zhang F; Li Y
Int J Rheum Dis; 2017 Aug; 20(8):1009-1015. PubMed ID: 26014903
[TBL] [Abstract][Full Text] [Related]
15. Immunopathogenesis of ANCA-Associated Vasculitis.
Kronbichler A; Lee KH; Denicolò S; Choi D; Lee H; Ahn D; Kim KH; Lee JH; Kim H; Hwang M; Jung SW; Lee C; Lee H; Sung H; Lee D; Hwang J; Kim S; Hwang I; Kim DY; Kim HJ; Cho G; Cho Y; Kim D; Choi M; Park J; Park J; Tizaoui K; Li H; Smith L; Koyanagi A; Jacob L; Gauckler P; Shin JI
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023023
[TBL] [Abstract][Full Text] [Related]
16. Eye involvement in ANCA positive vasculitis.
Macarie SS; Kadar A
Rom J Ophthalmol; 2020; 64(1):3-7. PubMed ID: 32292850
[TBL] [Abstract][Full Text] [Related]
17. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
Lally L; Spiera R
Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
[TBL] [Abstract][Full Text] [Related]
18. [Anti-neutrophil cytoplasmic antibodies (ANCA) associated vasculitides].
Kaliterna DM; Marinović I; Salamunić I
Reumatizam; 2013; 60(2):43-6. PubMed ID: 24979996
[TBL] [Abstract][Full Text] [Related]
19. Anti-neutrophil cytoplasmic antibody-associated vasculitis, large vessel vasculitis and Kawasaki disease in Japan.
Kobayashi S; Fujimoto S; Takahashi K; Suzuki K
Kidney Blood Press Res; 2010; 33(6):442-55. PubMed ID: 21071954
[TBL] [Abstract][Full Text] [Related]
20. [Review article: Antineutrophil cytoplasmic antibody in small vessel vasculitis].
Nakano H; Ozaki S
Rinsho Byori; 2010 May; 58(5):480-9. PubMed ID: 20560457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
